Patents by Inventor Christina Bailey-Hytholt

Christina Bailey-Hytholt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIFUNGAL NANOPARTICLES FOR TARGETED TREATMENT OF FUNGAL INFECTIONS
    Publication number: 20220160631
    Abstract: The invention provides functionalized antifungal-loaded liposomal formulations targeting Candida, which minimize damage to healthy human cells, limit antimicrobial exposure, and reduce the development of antifungal resistance.
    Type: Application
    Filed: January 31, 2022
    Publication date: May 26, 2022
    Inventors: Anita Shukla, Sarah Cowles, Noel Vera-Gonzalez, Christina Bailey-Hytholt, Eli Silvert
  • Antifungal nanoparticles for targeted treatment of fungal infections
    Patent number: 11273124
    Abstract: The invention provides functionalized antifungal-loaded liposomal formulations targeting Candida, which minimize damage to healthy human cells, limit antimicrobial exposure, and reduce the development of antifungal resistance.
    Type: Grant
    Filed: March 24, 2020
    Date of Patent: March 15, 2022
    Assignee: Brown University
    Inventors: Anita Shukla, Sarah Cowles, Noel Vera-Gonzalez, Christina Bailey-Hytholt, Eli Silvert
  • PLACENTAL LIPID BILAYER FOR CELL-FREE MOLECULAR INTERACTION STUDIES
    Publication number: 20200370008
    Abstract: The invention provides a lipid bilayer mimicking the lipid composition of the placenta. The lipid composition provides an in vitro placenta model using the lipid composition of the placental cell membrane.
    Type: Application
    Filed: March 18, 2020
    Publication date: November 26, 2020
    Inventors: Anita Shukla, Christina Bailey-Hytholt, Anubhav Tripathi
  • ANTIFUNGAL NANOPARTICLES FOR TARGETED TREATMENT OF FUNGAL INFECTIONS
    Publication number: 20200368160
    Abstract: The invention provides functionalized antifungal-loaded liposomal formulations targeting Candida, which minimize damage to healthy human cells, limit antimicrobial exposure, and reduce the development of antifungal resistance.
    Type: Application
    Filed: March 24, 2020
    Publication date: November 26, 2020
    Inventors: Anita Shukla, Sarah Cowles, Noel Vera-Gonzalez, Christina Bailey-Hytholt, Eli Silvert